mibefradil has been researched along with Gastric Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avci, B; Banoğlu, ZN; Bilici, D; Bilici, S; Ciftçioğlu, A; Kiziltunç, A | 1 |
1 other study(ies) available for mibefradil and Gastric Diseases
| Article | Year |
|---|---|
Antioxidant effect of T-type calcium channel blockers in gastric injury.
Topics: Animals; Antioxidants; Calcium Channel Blockers; Calcium Channels, T-Type; Ethanol; Gastric Mucosa; Glutathione; Glutathione Reductase; Mibefradil; Rats; Rats, Sprague-Dawley; Stomach Diseases | 2002 |